Beam Therapeutics Inc. (BEAM)
NASDAQ·Healthcare·Biotechnology
$24.12
-1.03%
Mkt Cap $3.05B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (19 analysts)
$52.00
Range $26.00 – $80.00
Implied Upside
+115.6%
Consensus $52.00 vs current $24.12
NASDAQ·Healthcare·Biotechnology
$24.12
-1.03%
Mkt Cap $3.05B
Buy
6
Hold
0
Sell
0
Price Target (19 analysts)
$52.00
Range $26.00 – $80.00
+115.6%
Consensus $52.00 vs current $24.12